Literature DB >> 15100669

Measurement of eotaxin (CCL11) in induced sputum supernatants: validation and detection in asthma.

Chrystalleni Hadjicharalambous1, Gordon Dent, Richard D May, Rachel L C Handy, Ian K Anderson, Donna E Davies, Ratko Djukanovic.   

Abstract

BACKGROUND: Induced sputum is widely used in asthma research; however, for many mediators, the detection methods have not been validated.
OBJECTIVE: We sought to optimize the method of detection of eotaxin, an important chemokine acting through the CCR3 receptor on eosinophils, basophils, and T(H)2 cells.
METHODS: Induced sputum from normal and asthmatic subjects was processed with dithioerythritol (DTE) or PBS; recovery of eotaxin was assessed by means of ELISA before and after spiking with recombinant eotaxin. Furthermore, the effects of removing DTE by means of ultrafiltration or the addition of protease inhibitors and high-speed centrifugation on endogenous levels and spiking recovery of eotaxin were assessed.
RESULTS: Endogenous eotaxin was undetectable in DTE-processed samples, with a mean of only 30% (SD, 13%) spike recovery. DTE had no effect on the immunoassay capture antibody but dramatically reduced the detection of recombinant eotaxin. Removal of DTE from sputum before immunoassay did not improve detection, although it restored the recovery of a subsequent eotaxin spike. In contrast, PBS-processed sputum resulted in an eotaxin spike recovery of 101% (SD, 20%). Addition of protease inhibitors or high-speed centrifugation had no effect on eotaxin detection. By using this optimized protocol, eotaxin levels in PBS-processed sputum samples were found to be significantly increased in asthmatic sputum (P<.05).
CONCLUSION: Measurement of eotaxin by means of immunoassay is adversely affected by DTE, possibly through irreversible denaturation of epitopes, which makes eotaxin undetectable by using the immunoassay antibody. Sputum samples should be processed into PBS for assessment of eotaxin, which is present at increased levels in asthmatic sputum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100669     DOI: 10.1016/j.jaci.2004.01.757

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels.

Authors:  Jyotsna Batra; Reenu Rajpoot; Jasmine Ahluwalia; Satish K Devarapu; Surendra K Sharma; Amit K Dinda; Balaram Ghosh
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

2.  Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease.

Authors:  Benjamin L Nicholas; Paul Skipp; Sheila Barton; Dave Singh; Dinesh Bagmane; Richard Mould; Gilbert Angco; Jon Ward; Binita Guha-Niyogi; Susan Wilson; Peter Howarth; Donna E Davies; Stephen Rennard; C David O'Connor; Ratko Djukanovic
Journal:  Am J Respir Crit Care Med       Date:  2010-01-28       Impact factor: 21.405

3.  Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.

Authors:  Marie-Chantal Larose; Anne-Sophie Archambault; Véronique Provost; Michel Laviolette; Nicolas Flamand
Journal:  Front Med (Lausanne)       Date:  2017-08-11

4.  Eotaxin and IL-4 levels are increased in induced sputum and correlate with sputum eosinophils in patients with nonasthmatic eosinophilic bronchitis.

Authors:  Rui Zhang; Wei Luo; Zhenyu Liang; Yaxia Tan; Ruchong Chen; Wenju Lu; Nanshan Zhong
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD.

Authors:  Alex Mulvanny; Caroline Pattwell; Augusta Beech; Thomas Southworth; Dave Singh
Journal:  Biomedicines       Date:  2022-08-11

6.  Persistence of oxidant and protease burden in the airways after smoking cessation.

Authors:  Noora Louhelainen; Paula Rytilä; Tari Haahtela; Vuokko L Kinnula; Ratko Djukanović
Journal:  BMC Pulm Med       Date:  2009-05-27       Impact factor: 3.317

7.  Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen.

Authors:  Rob G J A Zuiker; Marcella K Ruddy; Nicoletta Morelli; Robin Mogg; Veronica M Rivas; Kristien van Dyck; Inge De Lepeleire; Michael R L Tanen; J Diderik Boot; Ingrid M C Kamerling; Zuzana Diamant
Journal:  Eur Clin Respir J       Date:  2015-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.